1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Eye Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharif, NA | 1 |
| Koutsilieris, M; Mavragani, CP; Moschos, MM; Nitoda, E | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Eye Diseases
| Article | Year |
|---|---|
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects.
Topics: Conjunctivitis, Allergic; Eye Diseases; Histamine; Humans; Inflammation; Platelet Activating Factor | 2022 |
Ocular actions of platelet-activating factor: clinical implications.
Topics: Animals; Eye Diseases; Humans; Inflammation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2012 |